Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| KD | Kyndryl | $10.71 | -$12.78 | -54.41% | 875.5K | $5.4B | $10.11$44.20 |
| PLYX | Polaryx Therapeutics | $6.00 | -$2.91 | -32.70% | 124K | $422M | $2.51$48.91 |
| PFSA | Profusa | $3.05 | -$1.32 | -30.25% | 287.8K | $378M | $2.90$957.00 |
| VHUB | VenHub Global | $3.59 | -$1.24 | -25.67% | 479.9K | $362M | $3.40$40.30 |
| MNDY | Monday.com | $76.18 | -$21.82 | -22.27% | 355.3K | $5.0B | $73.01$342.64 |
| PGY | Pagaya Technologies | $14.75 | -$3.89 | -20.87% | 702.9K | $1.5B | $8.50$44.99 |
| RDIB | Reading International | $10.79 | -$2.67 | -19.84% | 27.3K | $306M | $5.81$17.40 |
| FLYE | Fly-E Group | $2.78 | -$0.68 | -19.65% | 15K | $5.6M | $2.50$161.80 |
| HIMS | Hims & Hers Health | $18.61 | -$4.41 | -19.16% | 3M | $5.2B | $16.36$72.98 |
| MPAA | Motorcar Parts Of America | $10.87 | -$2.27 | -17.27% | 237.1K | $257M | $6.04$18.12 |
| CLF | Cleveland-Cliffs | $12.21 | -$2.52 | -17.11% | 1.9M | $8.4B | $5.63$16.70 |
| SXTC | China Sxt Pharmaceuticals | $2.55 | -$0.45 | -15.00% | 4.4M | $2.6M | $2.34$1,176.00 |
| MAXN | Maxeon Solar Technologies | $3.32 | -$0.58 | -14.78% | 10.8K | $66M | $2.46$6.02 |
| IBG | Innovation Beverage Group | $4.11 | -$0.67 | -14.02% | 55.2K | $3.3M | $3.27$49.25 |
| OBAI | Tg-17 | $16.43 | -$2.57 | -13.53% | 11.3K | $61M | $16.43$38.50 |
| ONEG | OneConstruction Group | $4.29 | -$0.62 | -12.63% | 91.7K | $79M | $1.00$13.50 |
| PLTZ | Tidal Trust II - Defiance Daily Target 2x Short Pltr ETF | $33.06 | -$4.73 | -12.51% | 1.8M | - | $19.91$75.28 |
| ALX | Alexander's | $224.66 | -$30.41 | -11.92% | 4.6K | $1.3B | $189.05$260.84 |
| WAT | Waters | $336.31 | -$44.98 | -11.80% | 1.4M | $23B | $275.05$414.15 |
| LVLU | Lulu's Fashion Lounge | $16.65 | -$1.61 | -8.82% | 53.8K | $51M | $2.98$32.32 |
Related Articles
Featured Article
Hims & Hers Takes On Novo Nordisk: What We Know Right Now
Travis Hoium|Feb 5, 2026
Hims & Hers fell on fear that Novo Nordisk would take action against the company's new oral GLP-1, but there's more to the story.
HUGE News: Hims & Hers Adds Cancer Testing to Labs Offering
Travis Hoium|Feb 4, 2026
Hims & Hers is moving beyond prescriptions to preventative testing.
Stocks to Love in 2026
Motley Fool Staff|Jan 11, 2026
Are you looking for investment opportunities in 2026?
Why Is Hims & Hers Stock Falling, and Should Investors Buy the Dip?
Parkev Tatevosian, CFA|Nov 26, 2025
The healthcare industry is ripe for disruption.
Monday.com Stock Is Crashing. Time to Buy the Dip?
Timothy Green|Nov 10, 2025
The software company's slight guidance cut tanked the stock.
Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock?
Geoffrey Seiler|Nov 9, 2025
The company continues to have a strong growth outlook ahead.
Hims & Hers Stock Jumps 9% After Huge Announcement
Travis Hoium|Oct 16, 2025
New products are coming to the Hers platform.
1 Growth Stock Down 30% You Don't Want to Miss On
Neil Rozenbaum|Oct 6, 2025
The recent pullback is a blessing in disguise.
Cleveland-Cliffs Stock Just Keeps Dropping. Buying Opportunity, or a Sign to Steer Clear?
Reuben Gregg Brewer|Oct 1, 2025
Cleveland-Cliffs is losing money as the steel industry deals with a downturn, which is exactly why you might want to buy it.
A Healthcare Debate: Progyny vs. Hims & Hers
Motley Fool Staff|Sep 26, 2025
Motley Fool analysts take a look.
